Search Results - "García León, Annabel"
-
1
Phytosterol‐mediated inhibition of intestinal cholesterol absorption in mice is independent of liver X receptor
Published in Molecular nutrition & food research (01-09-2017)“…Scope Previous studies have proposed that phytosterols activate liver X receptors (LXR) in the intestine, thereby reducing intestinal cholesterol absorption…”
Get full text
Journal Article -
2
Consumption of polyunsaturated fat improves the saturated fatty acid‐mediated impairment of HDL antioxidant potential
Published in Molecular nutrition & food research (01-10-2015)“…SCOPE: The present study aimed to compare the effects of diets containing high‐fat, high‐cholesterol and saturated fatty acids (HFHC‐SFA) and…”
Get full text
Journal Article -
3
Impaired HDL (High-Density Lipoprotein)-Mediated Macrophage Cholesterol Efflux in Patients With Abdominal Aortic Aneurysm-Brief Report
Published in Arteriosclerosis, thrombosis, and vascular biology (01-11-2018)“…Objective- The ability of HDL (high-density lipoprotein) to promote macrophage cholesterol efflux is considered the main HDL cardioprotective function…”
Get full text
Journal Article -
4
Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models
Published in Cancers (23-12-2022)“…Patients with advanced endometrial cancer (EC) show poor outcomes. Thus, the development of new therapeutic approaches to prevent metastasis development in…”
Get full text
Journal Article -
5
Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles
Published in European journal of pharmaceutics and biopharmaceutics (01-09-2024)“…[Display omitted] Surface-exposed calreticulin (CRT) serves as a crucial cell damage-associated molecular pattern for immunogenic apoptosis, by generating an…”
Get full text
Journal Article -
6
A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4+ lymphoma cells without toxicity in immunocompromised and immunocompetent mice
Published in Biomedicine & pharmacotherapy (01-06-2022)“…High rates of relapsed and refractory diffuse large B-cell lymphoma (DLBCL) patients and life-threatening side effects associated with immunochemotherapy make…”
Get full text
Journal Article -
7
ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer
Published in Scientific reports (03-11-2016)“…Low levels of high-density lipoprotein cholesterol (HDLc) have been associated with breast cancer risk, but several epidemiologic studies have reported…”
Get full text
Journal Article -
8
Time-Prolonged Release of Tumor-Targeted Protein-MMAE Nanoconjugates from Implantable Hybrid Materials
Published in Pharmaceutics (14-01-2022)“…The sustained release of small, tumor-targeted cytotoxic drugs is an unmet need in cancer therapies, which usually rely on punctual administration regimens of…”
Get full text
Journal Article -
9
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo
Published in Pharmaceutics (22-02-2023)“…Despite advances in the development of targeted therapies for acute myeloid leukemia (AML), most patients relapse. For that reason, it is still necessary to…”
Get full text
Journal Article -
10
A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse model
Published in Biomaterials (01-01-2022)“…Current therapy in acute myeloid leukemia (AML) is based on chemotherapeutic drugs administered at high doses, lacking targeting selectivity and displaying…”
Get full text
Journal Article -
11
LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis: Insight From Mouse Models
Published in Circulation research (28-08-2020)“…RATIONALE:The HDL-mediated stimulation of cellular cholesterol efflux initiates the reverse cholesterol pathway from macrophages (m-RCT), which ends in the…”
Get full text
Journal Article -
12
Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness
Published in Scientific reports (16-07-2019)“…Cholesterol mediates its proliferative and metastatic effects via the metabolite 27-hydroxycholesterol (27-HC), at least in breast and endometrial cancer. We…”
Get full text
Journal Article -
13
ApoA-I Mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer
Published in Scientific reports (03-11-2016)“…Low levels of high-density lipoprotein cholesterol (HDLc) have been associated with breast cancer risk, but several epidemiologic studies have reported…”
Get full text
Journal Article -
14
ApoA-I Mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer
Published in Scientific reports (03-11-2016)“…Low levels of high-density lipoprotein cholesterol (HDLc) have been associated with breast cancer risk, but several epidemiologic studies have reported…”
Get full text
Journal Article -
15
Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral β-amyloidosis
Published in Scientific reports (07-11-2017)“…Cerebral β-amyloidosis is a major feature of Alzheimer’s disease (AD), characterized by the accumulation of β-amyloid protein (Aβ) in the brain. Several…”
Get full text
Journal Article -
16
Impaired HDL (High-Density Lipoprotein)-Mediated Macrophage Cholesterol Efflux in Patients With Abdominal Aortic Aneurysm
Published in Arteriosclerosis, thrombosis, and vascular biology (20-09-2018)“…OBJECTIVE—The ability of HDL (high-density lipoprotein) to promote macrophage cholesterol efflux is considered the main HDL cardioprotective function…”
Get full text
Journal Article -
17
Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery
Published in Journal of controlled release (01-03-2022)“…Self-assembling non-immunoglobulin scaffold proteins are a promising class of nanoscale carriers for drug delivery and interesting alternatives to…”
Get full text
Journal Article